This infection can be inhibited by N-acetylglucosamine β1–2 mannose (a target for LSECtin) but not by mannan (a target for DC-SIGN/L-SIGN) [286]; however, the underlying mechanism of LSECtin in JEV entry has not been fully defined. This evidence concerns the gene CD209 and infection.